Family Office Briefing on research byMatthews·Sep 17, 2025
Life Sciences Industry Is The Next CRE Investor Favorite
Life sciences sector poised for growth — family offices should consider co-GP opportunities with specialized operators.
Quantitative metrics for this report are published by Matthews in the full report. Read it directly below for the underlying data tables.
Full report
Matthews
Building a thesis around Life Science? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.